Trials / Conditions / Secondary Hyperoxaluria
Secondary Hyperoxaluria
4 registered clinical trials studyying Secondary Hyperoxaluria.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephr NCT03346369 | Universitair Ziekenhuis Brussel | Phase 3 |
| Completed | A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria NCT03095885 | Allena Pharmaceuticals | N/A |
| Completed | Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidne NCT02547805 | Allena Pharmaceuticals | Phase 2 |
| Completed | Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones NCT02503345 | Allena Pharmaceuticals | Phase 2 |